Keith Manchester MD

Keith Manchester MD General Information

Biography

Dr. Keith Manchester serves as Partner and Portfolio Manager at QVT Financial. He serves as a Director at Roivant Sciences. He also serves as a Board Member at Arbutus Biopharma. He has also served as a director of our subsidiary Arbutus Inc. since November 2014. He serves as a Partner and the Head of Life Sciences at QVT Financial, New York, USA, an investment firm, where he has been employed since 2005. He focuses on investments in both publicly traded and privately owned life science companies. Prior to joining QVT, Dr. Manchester was Vice President of Business Development from 2002 to 2004 and Director of Business Development from 2000 to 2002 at Applied Molecular Evolution, a biotechnology company. From 1999 to 2000, Dr. Manchester was an associate at Vestar Capital Partners, a private equity firm. From 1997 to 1999, Dr. Manchester was an investment banker in the healthcare group at Goldman, Sachs & Co. Dr. Manchester serves as a director for the following companies: Roivant Sciences Ltd., Roivant Sciences, Inc., Arbutus Biopharma Corporation, and Kriya Therapeutics. Dr. Manchester also sits on the Supervisory Board of Medigene AG. He received his A.B. from Harvard College and his M.D. from Harvard Medical School.